PDB16 INSULIN GLARGINE IS ASSOCIATED WITH A LOWER INCIDENCE OF DIABETIC FOOT SYNDROME AND MACROVASCULAR COMPLICATIONS COMPARED TO NPH INSULIN IN TYPE 2 DIABETICS UNDER GERMAN REAL-LIFE CONDITIONS
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72074-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)72074-5/fulltext
Title :
PDB16 INSULIN GLARGINE IS ASSOCIATED WITH A LOWER INCIDENCE OF DIABETIC FOOT SYNDROME AND MACROVASCULAR COMPLICATIONS COMPARED TO NPH INSULIN IN TYPE 2 DIABETICS UNDER GERMAN REAL-LIFE CONDITIONS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72074-5&doi=10.1016/S1098-3015(11)72074-5
First page :
A286
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
233